Skip to main content
. 2015 Aug 3;30(10):1665–1673. doi: 10.1093/ndt/gfv302

FIGURE 1:

FIGURE 1:

Patient disposition. *The AEs in the roxadustat arm were acute prostatitis (in the 1.0 mg/kg TIW group) and elevated liver enzymes (in the 2.0 mg/kg BIW group). One placebo patient was discontinued because of SAEs of acute pericarditis and renal failure.